How to treat lung metastasis of nasopharyngeal carcinoma

How to treat lung metastasis from nasopharyngeal carcinoma?

1. Most nasopharyngeal carcinomas are poorly differentiated squamous cell carcinomas, so radiotherapy is the first choice for 60Co or linear accelerator high-energy radiotherapy. The 5-year survival rate of radiotherapy is about 45%. Local recurrence and metastasis of nasopharyngeal carcinoma after radiotherapy is the main cause of death. Some patients with external irradiation of 60-70Gy still have residual local lesions, which can be combined with intracavitary afterloading therapy. Because nasopharyngeal carcinoma patients are affected by the disease, have a heavy psychological burden, poor appetite, and low resistance, family members should be guided to encourage patients to eat, and give them high-protein, high-vitamin, low-fat, and easily digestible food.

2. Biological immunotherapy is harmless and has no toxic side effects to patients with nasopharyngeal carcinoma lung metastasis. It is an autologous immune cell technology that uses certain biotechnologies to cultivate DC immune cells and CIK tumor-killing cells in high-standard laboratories. Then, a unique double-culture and double-infusion method is used to double-culture and double-infusion DC and CIK combined cells to directly kill cancer cells and rebuild the autoimmune system.

3. Biological immunotherapy mainly uses DC and CIK cells to fight cancer cells together. Dendritic cells DC are like "radars" that can actively search and identify cancer cells; CIK cells with cell induction function are like "missiles" that can accurately kill cancer cells without damaging any normal tissues, effectively kill tumor tissues, and improve immunity.